Literature DB >> 14738452

Detection of HLA class II-dependent T helper antigen using antigen phage display.

R Somasundaram1, K Satyamoorthy, L Caputo, H Yssel, D Herlyn.   

Abstract

Major histocompatibility complex (MHC) class II-dependent antigens not only activate CD4+ T helper (Th) cells, but also cytolytic T lymphocytes and effector cells of the innate immune system. These antigens therefore are candidate vaccines against cancer and infectious agents. We have developed a novel approach using a model antigen, tetanus toxoid (TT), which provides the basis for the establishment of a novel strategy of cloning Th antigens. In the TT model system, a cDNA library encoding part of the TT light chain which contained a TT-associated Th epitope recognized by TT-specific Th clones was displayed on a phage vector (TT-phage) and presented to TT-specific Th cells by autologous Epstein-Barr virus-transformed B cells (APC). These TT-phages were able to specifically activate two different TT-specific CD4+ Th cell lines as demonstrated both in [3H]thymidine incorporation and cytokine release assays. Th cell stimulation by TT-phages was significant at a ratio of one TT-phage in 50 irrelevant phages. The described approach provides the basis for the development of a novel strategy of cloning MHC class II-dependent Th antigens, using available Th cells. This strategy has several potential advantages over existing antigen cloning methods or biochemical peptide isolation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14738452      PMCID: PMC1808955          DOI: 10.1111/j.1365-2249.2003.02366.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Expression cloning of a protective Leishmania antigen.

Authors:  E Mougneau; F Altare; A E Wakil; S Zheng; T Coppola; Z E Wang; R Waldmann; R M Locksley; N Glaichenhaus
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

Review 2.  Tumor immunotherapy: the tumor cell as an antigen-presenting cell.

Authors:  S Ostrand-Rosenberg
Journal:  Curr Opin Immunol       Date:  1994-10       Impact factor: 7.486

3.  Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage.

Authors:  A Meola; P Delmastro; P Monaci; A Luzzago; A Nicosia; F Felici; R Cortese; G Galfrè
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

4.  Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.

Authors:  E A Walter; P D Greenberg; M J Gilbert; R J Finch; K S Watanabe; E D Thomas; S R Riddell
Journal:  N Engl J Med       Date:  1995-10-19       Impact factor: 91.245

5.  Structural mimicry and enhanced immunogenicity of peptide epitopes displayed on filamentous bacteriophage. The V3 loop of HIV-1 gp120.

Authors:  F di Marzo Veronese; A E Willis; C Boyer-Thompson; E Appella; R N Perham
Journal:  J Mol Biol       Date:  1994-10-21       Impact factor: 5.469

6.  Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells.

Authors:  R F Wang; X Wang; S A Rosenberg
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

Review 7.  The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses.

Authors:  S A Kalams; B D Walker
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

8.  Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.

Authors:  L Zitvogel; J I Mayordomo; T Tjandrawan; A B DeLeo; M R Clarke; M T Lotze; W J Storkus
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

9.  Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice.

Authors:  S Baskar; L Glimcher; N Nabavi; R T Jones; S Ostrand-Rosenberg
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

10.  Identification of a CD4+ T cell-stimulating antigen of pathogenic bacteria by expression cloning.

Authors:  S Sanderson; D J Campbell; N Shastri
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  4 in total

1.  Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections.

Authors:  Christiane Beckmann; Mitchell Brittnacher; Robert Ernst; Nicole Mayer-Hamblett; Samuel I Miller; Jane L Burns
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Estimation of low frequency antigen-presenting cells with a novel RELISPOT assay.

Authors:  Amiran K Dzutsev; Igor M Belyakov; Dmitry V Isakov; Susan J Gagnon; David H Margulies; Jay A Berzofsky
Journal:  J Immunol Methods       Date:  2008-02-08       Impact factor: 2.303

3.  HLA Class II Specificity Assessed by High-Density Peptide Microarray Interactions.

Authors:  Thomas Osterbye; Morten Nielsen; Nadine L Dudek; Sri H Ramarathinam; Anthony W Purcell; Claus Schafer-Nielsen; Soren Buus
Journal:  J Immunol       Date:  2020-06-01       Impact factor: 5.422

4.  T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment.

Authors:  Keith R Miller; Akiko Koide; Brenda Leung; Jonathan Fitzsimmons; Bryan Yoder; Hong Yuan; Michael Jay; Sachdev S Sidhu; Shohei Koide; Edward J Collins
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.